Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel

NCT04471675 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Albumin-bound docetaxel

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.